The Fourth Annual Transplant Golf Classic
The Fourth Annual Transplant Golf Classic was our best by far, raising more than $100,000! Nearly 100 golfers enjoyed a challenging course under very good conditions. Many of them stayed for our evening program which featured remarks by Dr. James Markmann, Chief of Transplant Surgery, Dr. Joren Madsen, Director of the Transplant Center and Dr. Peter Slavin, President of Massachusetts General Hospital. In addition, the audience heard riveting testimonials from two transplant patients themselves—Peter Keating, an altruistic kidney donor, and Brian Primack, who at the time of the event was awaiting a heart transplant (he has since been successfully transplanted!) Peter and Brian’s stories emphasized the life-saving care provided by the MGH Transplant Center and the extraordinary research being conducted that will both increase the number of available organs, and improve the quality of life for transplant recipients.
Nearly 120,000 Americans are currently awaiting organ transplantation. Yet, fewer than 30,000 transplants were performed in 2011. The only solution is basic research like that being conducted by the team of transplant scientists at Mass General. Your contributions to the 2013 Transplant Golf Classic will support this important work.
Thank You to Our Sponsors
- CliftonLarsonAllen LLP
- Willow Tree Poultry Farm, Inc.
- Clearview National Partners
- Nixon Peabody LLP
- Mass General Department of Surgery
- Genentech Inc.
- Liberty Mutual Insurance
- Bank of America, Merrill Lynch
- Wadsworth Medical Technologies, Inc.
- Heritage Financial Services
- Back Bay Properties
- RehabCare Group, Inc.
Mass General is grateful for the support of its sponsors, but it does not endorse their products or services
Proceeds to benefit Mass General Transplant Research
Transplantation provides a life-saving therapy for tens of thousands of Americans each year. However, a major problem facing all transplant recipients is the need for lifelong immunosuppression to prevent transplant rejection. While highly effective, these medications come with the risk of serious short- and long-term complications. Finding a way to transplant without these medicines depends on advances from basic research. It is in this area that Mass General transplant physicians and scientists are world leaders. In 2008, the MGH team reported the first successful protocol that allows kidney transplantation without immunosuppression. The first patient treated with this groundbreaking approach recently celebrated her 10 year anniversary of being off immunosuppression. To make this discovery more widely applicable to transplants of other organs and patients already transplanted, more research is needed. It is toward these pioneering efforts that your contributions will have great impact.